During this presentation we welcome, Kiora Pharmaceuticals. Kiora (Nasdaq: KPRX) is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases.

This Company Webcast was recorded during the Lytham Partners Fall 2024 Investor Conference.